Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026)
Travere Therapeutics (TVTX) posted Exchange Rate Effect of -$60000.0 for Q1 2026, up 85.47% on a QoQ basis from -$413000.0 in Q4 2025, and down 110.95% year-over-year from $548000.0 in Q1 2025.
Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Travere Therapeutics' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$60000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 110.95% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 2437.5% YoY) and the FY2025 annual result came in at $2.3 million, up 350.93% from the prior year.
- Exchange Rate Effect was -$60000.0 for Q1 2026 at Travere Therapeutics, up from -$413000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.9 million in Q2 2025 and bottomed at -$1.7 million in Q2 2022.
- A 5-year average of $29705.9 and a median of -$60000.0 in 2026 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 3085.71% — and 2025, when it soared 1888.07%.
- Travere Therapeutics' Exchange Rate Effect stood at $1.1 million in 2022, then gained by 7.89% to $1.2 million in 2023, then tumbled by 178.31% to -$964000.0 in 2024, then surged by 57.16% to -$413000.0 in 2025, then surged by 85.47% to -$60000.0 in 2026.
- Business Quant data shows TVTX's Exchange Rate Effect at -$60000.0 in Q1 2026, -$413000.0 in Q4 2025, and $207000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | -60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 548,000.00 |
| Mar 31, 2025 | 548,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | -293,000.00 |
| Mar 31, 2024 | -293,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Dec 31, 2023 | 1.23 Mn |